The Swiss MR-in-RT Symposium 2026 brings together international experts to discuss current developments and future perspectives in MR-guided radiotherapy. From adaptive treatment concepts and workflow integration to AI-supported innovation and translational research, the symposium provides concise insights into how MR technologies are advancing precision radiation oncology.
Hybrid
Universitätsspital Zürich, Rämistrasse 100, 8091 Zürich
Grosser Hörsaal PATH / D22
13.11.2026
08:45 - 16:00
to be announced
Free of charge
| 08:45 | Registration, Coffee and Gipfeli |
| 09:15 | Welcome & Introduction Sebastian M. Christ, University Hospital Zurich, Switzerland |
| Session 1: Clinical Impact of MR-in-RT Thomas Zilli, Ente Ospedaliero Cantonale, Switzerland and Daniel Aebersold, Inselspital, University Hospital Bern, Switzerland |
|
| 09:30 | MR-enhanced ART: What is the Clinical Evidence to date? Juliane Hörner-Rieber, University Hospital Düsseldorf, Germany |
| 09:50 | MR-enhanced ART in the Thorax: Managing Motion, Margins, and Risk Fabian Weykamp, University Hospital Heidelberg, Germany |
| 10:10 | MR-adaptive ART in the Head & Neck Space: Results of the MARTHA Study Panagiotis Balermpas, University Hospital Zurich, Switzerland |
| 10:30 | How to design the next generation of MR-enhanced ART clinical trials Michael Chuong, Miami Cancer Institute, Florida, USA |
| 10:50 | Coffee Break |
| Session 2: Implementing MR-in-RT Moderated by Jakob Liermann, Heidelberg University Hospital, Germany and Christoph Bert, University Hospital Erlangen / FAU Erlangen-Nürnberg, Germany |
|
| 11:20 | Implementing MR-in-RT at Scale: Lessons from Early Adopters Martin Fast, University Medical Center Utrecht, The Netherlands |
| 11:40 | Dose Accumulation in ART: Are We Measuring What We Think We Are? Francesca Albertini, Paul Scherrer Institut PSI, Aargau, Switzerland |
| 12:00 | Workflow, Throughput, Economics: Can MR-enhanced ART be sustainable? Tobias Finazzi, Kantonsspital Baden, Switzerland |
| 12:20 | Lunch Break |
| Session 3: Technology, AI & Advanced Imaging Moderated by Oliver Riesterer, Kantonsspital Aarau, Switzerland and Stephanie Corradini, LMU-Hospital Munich, Germany |
|
| 13:20 | Planning MR, MR-Only and MR-First Planning: Technology is ready – are we? Riccardo dal Bello, University Hospital Zurich, Switzerland |
| 13:40 | Functional low-field MR, Radiomics, AI: What can we translate into clinics? Jessica Scholey, University of California San Francisco, California, USA |
| Session 4: Podium Discussion Moderated by Sebastian M. Christ, University Hospital Zurich, Switzerland |
|
| 14:00 | Podium Discussion: “Are we over-engineering RT through the use of MR?” Michael Chuong, Miami Cancer Institute, Florida, USA Stefanie Corradini, LMU-Hospital Munich, Germany Juliane Hörner-Rieber, University Hospital Düsseldorf, Germany Jessica Scholey, University of California San Francisco, California, USA |
| 14:45 | Closing Remarks Sebastian M. Christ, University Hospital Zurich, Switzerland |
| 15:00 | Coffee Break |
| Session 5: Latest Innovation at USZ Moderated by Stephanie Tanadini-Lang, University Hospital Zurich, Switzerland |
|
| 15:30 | Shaping the Future of Radiation Oncology: Innovation & Insights at USZ Matthias Guckenberger, University Hospital Zurich, Switzerland |
| 16:30 | Innovation in Action: A Guided Tour of USZ’s Latest Advances Sebastian M. Christ, University Hospital Zurich, Switzerland |
| 17:00 | Closing Apéro |
Magnetic Resonance (MR) in radiation therapy is redefining precision oncology by enabling superior soft-tissue imaging, adaptive treatment, and real-time monitoring. Its clinical impact is increasingly evident across tumor sites, while technological advances—from functional low-field MR to AI-driven planning—are unlocking new opportunities for personalized care.
The Swiss MR-in-RT Symposium 2026 convenes leading experts to explore the clinical applications, technological innovations, and implementation challenges of MR-guided radiation therapy. Participants will gain practical perspectives from early adopters, learn about evolving adaptive treatment strategies, and discuss future directions in workflow optimization, sustainability, and clinical research.
Join us in person at the University Hospital Zurich or online to engage with the latest advances in MR-guided radiation oncology.
With kind regards,
Matthias Guckenberger & Sebastian M. Christ
Please register by November 6, 2026.